Gene: Plxna3
Official Full Name: plexin A3provided by MGI
Gene Summary: Enables semaphorin receptor activity. Involved in nervous system development; positive regulation of cytoskeleton organization; and semaphorin-plexin signaling pathway. Acts upstream of or within several processes, including hippocampus development; negative regulation of axon extension involved in axon guidance; and neuron development. Predicted to be part of semaphorin receptor complex. Predicted to be active in plasma membrane. Is expressed in several structures, including alimentary system; central nervous system; genitourinary system; peripheral nervous system; and sensory organ. Orthologous to human PLXNA3 (plexin A3). [provided by Alliance of Genome Resources, Apr 2025]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO01219 | Plxna3 Knockout cell line(SL4) | Mouse | Plxna3 | 1:3-1:4 | Negative | Online Inquiry |
Plxna3 Gene Knockout Cell Lines refer to genetically engineered cell lines in which the Plxna3 gene, also known as plexin A3, has been selectively disrupted or "knocked out." This gene plays a pivotal role in the neuronal signaling pathways mediated by semaphorins, which are crucial for various biological processes, including cell migration, axon guidance, and synaptic plasticity. By employing advanced CRISPR-Cas9 or other gene-editing technologies, these knockout cell lines facilitate the in-depth exploration of Plxna3's functional relevance in cell behavior and disease models.
The primary mechanism underlying these cell lines involves the loss of Plxna3 expression, leading to alterations in associated intracellular signaling cascades. Researchers can leverage these knockouts to elucidate the gene's role in neuronal development and disorders, ranging from neurodegenerative diseases to psychiatric conditions. This makes Plxna3 knockout cell lines invaluable tools for both fundamental research and translational studies aimed at developing targeted therapies.
One of the significant advantages of using Plxna3 knockout cell lines lies in their precision and reproducibility. Unlike traditional methods, these cell lines provide a consistent genetic background, minimizing variability in experimental outcomes. Compared to alternative models, such as siRNA-mediated knockdown, the knockout approach ensures complete absence of the gene, thereby allowing for a clearer interpretation of phenotypic effects. This completeness contributes to more reliable data, which is paramount in both academic and clinical research settings.
For researchers and clinicians focused on understanding the complexities of neural processes and the pathophysiology of diseases, Plxna3 gene knockout cell lines represent a substantial asset. They not only support the dissection of cellular mechanisms but also pave the way for the identification of novel therapeutic targets that can later be translated into clinical applications.
With an established legacy in the provision of cutting-edge biological products, our company specializes in delivering high-quality and precise genetic tools such as the Plxna3 gene knockout cell lines. We are committed to advancing scientific research and fostering innovations that lead to breakthroughs in various biological fields.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.